The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced ...
read more
The FDA approved Tecelra (afamitresgene autoleucel), a gene therapy indicated for the treatment of adults with unresectable or metastatic synovial ...
read more
SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving both the small molecule and cell & gene ...
read more
MIP Discovery announced the company’s rebrand to Tozaro, completing its transition to becoming a technology innovator in the cell and gene therapy (...
read more
Wednesday, August 07, 2024
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entered into a License Agreement ...
read more
Merck and Curon Biopharmaceutical have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire CN201, a ...
read more
NSG BioLabs, a Singapore-based provider of biotech co-working laboratory and office space, and the Life Science business of Merck Singapore, announced...
read more
Pfizer Inc. and BioNTech SE announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate ...
read more
Bristol Myers Squibb announced that the European Medicines Agency (EMA) has validated its Type II variation application to expand the indication for ...
read more
Biotechnology companies and research organizations in UK and Canada are entering into a R&D project jointly funded by a £1.1 million grant from ...
read more
Pfizer Inc. and BioNTech SE announced that the FDA approved the supplemental Biologics License Application for individuals 12 years of age and older (...
read more
Ascend Advanced Therapies has added new members to the Executive Team. Scott Broughton assumed the role of Chief Commercial Officer in mid-August. ...
read more
UCLA has received a $120 million commitment from surgeon, inventor and philanthropist Dr. Gary Michelson and his wife, Alya, to kick-start the ...
read more
Johnson & Johnson announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking the first ...
read more
Tuesday, September 03, 2024
Longeveron Inc. announced the positive Type C meeting with the FDA, supporting the advancement of Lomecel-B™, a proprietary, scalable, allogeneic, ...
read more